Archive | Maryland

MaxCyte Progresses Phase I Clinical Trial of Lead mRNA-based Cell Therapy from its CARMA™ Platform

MAXCYTE-New-Logo-2016-LARGE

–      No dose-limiting toxicities or safety concerns observed in first cohort of treated patients–      Feasibility of streamlined, faster CAR therapy manufacturing process confirmed–      Dosing initiated in second cohort of patients Gaithersburg, Maryland – May 8, 2019: MaxCyte, the global clinical-stage cell-based therapies and life sciences company, announced today that it […]

Comments Off on MaxCyte Progresses Phase I Clinical Trial of Lead mRNA-based Cell Therapy from its CARMA™ Platform Continue Reading →

UMB startup CoapTech receives FDA clearance for feeding tube placement device

coaptech logo

The company’s device uses ultrasound, which will allow a feeding tube to be placed without need for a surgical setting. With regulatory approval, it’s taking a key step toward commercialization. Baltimore-based medical device startup CoapTech reached a key milestone in April: It can now market its product that allows the placement of a feeding tube without the […]

Comments Off on UMB startup CoapTech receives FDA clearance for feeding tube placement device Continue Reading →

GlycoMimetics Announces Enrollment of First Patient in NCI-Sponsored Phase 3 Trial of Uproleselan in AML

logo-glyco

Evaluating previously untreated newly diagnosed adults with acute myeloid leukemia (AML) who are fit for intensive chemotherapySecond initiation among three late-stage uproleselan clinical trials ROCKVILLE, Md.–(BUSINESS WIRE)–Apr. 23, 2019– GlycoMimetics, Inc. (NASDAQ: GLYC) announced today dosing of the first patient in a Phase 3 clinical trial being conducted under the auspices of a Cooperative Research and Development Agreement […]

Comments Off on GlycoMimetics Announces Enrollment of First Patient in NCI-Sponsored Phase 3 Trial of Uproleselan in AML Continue Reading →

Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion

Catalent_Biologics-1080x675

Will provide new expertise and capabilities in one of the fastest-growing areas of healthcare, positioning Catalent for accelerated long-term growth SOMERSET, N.J. and BALTIMORE, M.D. – April 15, 2019 – Catalent, Inc. (NYSE: CTLT), the leading global diversified provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, and Paragon Bioservices, […]

Comments Off on Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion Continue Reading →

AURP Announces Brian Darmody as New CEO and Launches ‘AURP HQ2’ in Washington, DC Area

B Darmody

The Association of University Research Park, a professional association of university-related research and science parks, announced the appointment of Brian Darmody, Associate Vice President of Corporate Engagement at the University of Maryland (UMD), as its new Chief Executive Officer (CEO). Additionally, the association has opened a new office at the UMD Discovery District in the Washington, DC area, to […]

Comments Off on AURP Announces Brian Darmody as New CEO and Launches ‘AURP HQ2’ in Washington, DC Area Continue Reading →

PressComm PR Client Rachel King, CoFounder and CEO, GlycoMimetics Inc. Featured on PharmaVOICE Podcast

King-Rachel-PVcom-FeaturedImage630x315-560x315

Rachel King has charted a unique career — from consultant to VC to startup to now CEO — and is leading a pioneering company in the use of glycobiology technology. Click here to listen to the podcast via Pharmavoice.com”

Comments Off on PressComm PR Client Rachel King, CoFounder and CEO, GlycoMimetics Inc. Featured on PharmaVOICE Podcast Continue Reading →

WBJ Viewpoint Piece from BHI’s Rich Bendis and UMD’s Brian Darmody on Boosting Federal Tech Transfer

img_KAP_BioInnovations_Rich_001--Edit

While Maryland boasts world-class universities and many private sector firms, the major reason it ranks No. 1 in the country in per capita research spending is the presence of 74 federal research laboratories, such as the National Institutes of Health. Our federal laboratories host supremely talented researchers, including Nobel Prize winners, and house some of […]

Comments Off on WBJ Viewpoint Piece from BHI’s Rich Bendis and UMD’s Brian Darmody on Boosting Federal Tech Transfer Continue Reading →

Innovative Anchor Ventures Event on “The New Fabric of Baltimore” Featured in BBJ

AnchorVentures-LinkedIn-ProfilePhoto

Why tech folks need designers: ‘If it’s not easy to wear, people won’t wear it.’ Entrepreneur Frederic Chanay has been working for seven years to design T-shirts and sports bras that are able to constantly collect biomedical data on the people wearing them. But he’s also discovered how important it is for those clothes to […]

Comments Off on Innovative Anchor Ventures Event on “The New Fabric of Baltimore” Featured in BBJ Continue Reading →

Maryland Tech Council Appoints Marty Rosendale Chief Executive Officer

mtclogo

Gaithersburg, Maryland (September 19, 2018) – The Maryland Tech Council (MTC), the state’s largest trade association supporting the technology and life sciences sectors, today announced the appointment of Marty Rosendale as Chief Executive Officer (CEO), effective immediately. “Marty is a long-time member of MTC and served as senior executive advisor of the Tech Council of Maryland […]

Comments Off on Maryland Tech Council Appoints Marty Rosendale Chief Executive Officer Continue Reading →

UM Ventures Announces UMB Entrepreneur of the Year

Griffith_Bartley3

After 1,250 heart transplants and 685 lung transplants, one would think Bartley P. Griffith could rest easy at night, knowing he had done everything possible for his patients. But for the past 20-plus years, Griffith has felt a void. As he expressed when he was named UMB Researcher of the Year in 2010 “my own […]